NANOGP8 and cancer: By contrast, as Jeter et al. (2011) pointed out, “NANOGP8 is the predominant ‘isoform’ [of the protein] expressed in cancer cells and may, therefore, have evolved new functions distinct from those of NANOG1 in ESCs [embryonic stem cells]” (p. 11).